Roivant Sciences (ROIV) Free Cash Flow (2020 - 2025)

Roivant Sciences has reported Free Cash Flow for 6 years, with the latest figure at -$593.5 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 11.51% year-over-year to -$593.5 million; the trailing twelve-month figure through Mar 2026 stood at -$995.4 million (up 12.09% YoY), and the FY2026 full-year result was -$758.6 million, up 10.13% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$593.5 million, down from -$193.5 million in the prior quarter.
• The five-year high for Free Cash Flow was -$123.4 million in Q3 2021, with the low at -$675.4 million in Q4 2022.
• Historically, Free Cash Flow has averaged -$344.6 million across 5 years, with a median of -$250.3 million in 2023.
• Annual changes were most pronounced in 2021 — Free Cash Flow slumped 199.26% — and 2025, when it rose 27.74%.
• Roivant Sciences' Free Cash Flow stood at -$541.4 million in 2021, then slipped by 24.74% to -$675.4 million in 2022, then increased by 2.6% to -$657.8 million in 2023, then fell by 1.95% to -$670.7 million in 2024, then increased by 11.51% to -$593.5 million in 2025.
• The last three Free Cash Flow figures came in at -$593.5 million (Q4 2025), -$193.5 million (Q3 2025), and -$208.4 million (Q2 2025), per Business Quant data.